Baseline characteristics and biochemical data of the diabetic patients by group.

<p>Baseline characteristics and biochemical data of the diabetic patients by group.</p

Scatter graphs demonstrating the correlations between the MMFA and EDTRS contrast acuity charts.

<p>High to moderate correlations shown at (a) high (100% for EDTRS charts, 80% for MMFA), (b) 25%, (c) 10%, and (d) 5% contrast levels.</p

Multiple linear regression analysis of MMFA scores at 80%, 25%, 10%, and 5% contrast levels in different stages of DR groups.

<p>Multiple linear regression analysis of MMFA scores at 80%, 25%, 10%, and 5% contrast levels in different stages of DR groups.</p

Multiple linear regression analysis of the MMFA scores at 80%, 25%, 10%, and 5% contrast levels for all participants.

<p>Multiple linear regression analysis of the MMFA scores at 80%, 25%, 10%, and 5% contrast levels for all participants.</p

Agreement and correlation of the MMFA and ETDRS tests at four contrast levels.

<p>Agreement and correlation of the MMFA and ETDRS tests at four contrast levels.</p

Mean scores of the MMFA in all participants by group.

<p>The total possible score of the MMFA is 84. (DR: diabetic retinopathy, NPDR: non-proliferative diabetic retinopathy, PDR: proliferative diabetic retinopathy, ME: macular edema).</p

Participant characteristics.

<p>Participant characteristics.</p

AUC (95% C.I.) of the ROC curve analysis to discriminate patients and controls, patients with DR and participants without DR, and patients with CSME and participants without CSME.

<p>AUC (95% C.I.) of the ROC curve analysis to discriminate patients and controls, patients with DR and participants without DR, and patients with CSME and participants without CSME.</p

Effects of kefir consumption on clinical assessment in osteoporotic patients.

<p>(<b>A</b>) Serum calcium. (<b>B</b>) Parathyroid hormone (PTH). (<b>C</b>) β C-Terminal telopeptide of type I collagen (β-CTX). (<b>D</b>) Osteocalcin. (<b>E</b>) Spine bone mineral density (BMD). (<b>F</b>) Femoral neck BMD. (<b>G</b>) Total hip BMD. *<i>P</i> < 0.05 vs. control group.</p

Flow diagram of patient recruitment and follow-up.

<p>Flow diagram of patient recruitment and follow-up.</p